These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 34390300)

  • 41. Comorbidity and Coaggregation of Major Depressive Disorder and Bipolar Disorder and Cannabis Use Disorder in a Controlled Family Study.
    Quick CR; Conway KP; Swendsen J; Stapp EK; Cui L; Merikangas KR
    JAMA Psychiatry; 2022 Jul; 79(7):727-735. PubMed ID: 35648395
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cigarette smoking and its relationship to mood disorder symptoms and co-occurring alcohol and cannabis use disorders following first hospitalization for bipolar disorder.
    Heffner JL; DelBello MP; Anthenelli RM; Fleck DE; Adler CM; Strakowski SM
    Bipolar Disord; 2012 Feb; 14(1):99-108. PubMed ID: 22329477
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cortical gamma-aminobutyric acid and glutamate in posttraumatic stress disorder and their relationships to self-reported sleep quality.
    Meyerhoff DJ; Mon A; Metzler T; Neylan TC
    Sleep; 2014 May; 37(5):893-900. PubMed ID: 24790267
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Glutamatergic Neurometabolite Levels in Bipolar Disorder: A Systematic Review and Meta-analysis of Proton Magnetic Resonance Spectroscopy Studies.
    Ino H; Honda S; Yamada K; Horita N; Tsugawa S; Yoshida K; Noda Y; Meyer JH; Mimura M; Nakajima S; Moriguchi S
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2023 Feb; 8(2):140-150. PubMed ID: 36754485
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dronabinol and lofexidine for cannabis use disorder: A randomized, double-blind, placebo-controlled trial.
    Levin FR; Mariani JJ; Pavlicova M; Brooks D; Glass A; Mahony A; Nunes EV; Bisaga A; Dakwar E; Carpenter KM; Sullivan MA; Choi JC
    Drug Alcohol Depend; 2016 Feb; 159():53-60. PubMed ID: 26711160
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Early antidepressant effect of memantine during augmentation of lamotrigine inadequate response in bipolar depression: a double-blind, randomized, placebo-controlled trial.
    Anand A; Gunn AD; Barkay G; Karne HS; Nurnberger JI; Mathew SJ; Ghosh S
    Bipolar Disord; 2012 Feb; 14(1):64-70. PubMed ID: 22329473
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial.
    Freeman TP; Hindocha C; Baio G; Shaban NDC; Thomas EM; Astbury D; Freeman AM; Lees R; Craft S; Morrison PD; Bloomfield MAP; O'Ryan D; Kinghorn J; Morgan CJA; Mofeez A; Curran HV
    Lancet Psychiatry; 2020 Oct; 7(10):865-874. PubMed ID: 32735782
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Investigation of anterior cingulate cortex gamma-aminobutyric acid and glutamate-glutamine levels in obsessive-compulsive disorder using magnetic resonance spectroscopy.
    Li Y; Zhang CC; Kathrin Weidacker ; Zhang Y; He N; Jin H; Chen W; Voon V; Edden RAE; Yan F
    BMC Psychiatry; 2019 May; 19(1):164. PubMed ID: 31146727
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The bidirectional relationships between alcohol, cannabis, co-occurring alcohol and cannabis use disorders with major depressive disorder: results from a national sample.
    Pacek LR; Martins SS; Crum RM
    J Affect Disord; 2013 Jun; 148(2-3):188-95. PubMed ID: 23260381
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biological rationale and potential clinical use of gabapentin and pregabalin in bipolar disorder, insomnia and anxiety: protocol for a systematic review and meta-analysis.
    Houghton KT; Forrest A; Awad A; Atkinson LZ; Stockton S; Harrison PJ; Geddes JR; Cipriani A
    BMJ Open; 2017 Mar; 7(3):e013433. PubMed ID: 28348186
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An investigation of the relationship between glutamate and resting state connectivity in chronic cannabis users.
    Newman SD; Cheng H; Kim DJ; Schnakenberg-Martin A; Dydak U; Dharmadhikari S; Hetrick W; O'Donnell B
    Brain Imaging Behav; 2020 Oct; 14(5):2062-2071. PubMed ID: 31302844
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A placebo controlled study of quetiapine-XR in bipolar depression accompanied by generalized anxiety with and without a recent history of alcohol and cannabis use.
    Gao K; Ganocy SJ; Conroy C; Brownrigg B; Serrano MB; Calabrese JR
    Psychopharmacology (Berl); 2017 Aug; 234(15):2233-2244. PubMed ID: 28536866
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pilot trial of gabapentin for the treatment of benzodiazepine abuse or dependence in methadone maintenance patients.
    Mariani JJ; Malcolm RJ; Mamczur AK; Choi JC; Brady R; Nunes E; Levin FR
    Am J Drug Alcohol Abuse; 2016 May; 42(3):333-40. PubMed ID: 26962719
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of tiagabine maintenance on cannabis effects and related behaviors in daily cannabis users.
    Wesley MJ; Westgate PM; Stoops WW; Kelly TH; Hays LR; Lile JA
    Exp Clin Psychopharmacol; 2018 Jun; 26(3):310-319. PubMed ID: 29863387
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A Magnetic Resonance Spectroscopy Study of Lovastatin for Treating Bipolar Mood Disorder: A 4-Week Randomized Double-Blind, Placebo- Controlled Clinical Trial.
    Lotfi M; Shafiee S; Ghanizadeh A; Sigaroudi MO; Razeghian L
    Recent Pat Inflamm Allergy Drug Discov; 2017; 10(2):133-141. PubMed ID: 27804862
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A pilot trial of adjunctive gabapentin in the treatment of bipolar disorder.
    McElroy SL; Soutullo CA; Keck PE; Kmetz GF
    Ann Clin Psychiatry; 1997 Jun; 9(2):99-103. PubMed ID: 9242896
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of N-acetylcysteine on brain glutamate levels and resting perfusion in schizophrenia.
    McQueen G; Lally J; Collier T; Zelaya F; Lythgoe DJ; Barker GJ; Stone JM; McGuire P; MacCabe JH; Egerton A
    Psychopharmacology (Berl); 2018 Oct; 235(10):3045-3054. PubMed ID: 30141055
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Psychostimulant drug effects on glutamate, Glx, and creatine in the anterior cingulate cortex and subjective response in healthy humans.
    White TL; Monnig MA; Walsh EG; Nitenson AZ; Harris AD; Cohen RA; Porges EC; Woods AJ; Lamb DG; Boyd CA; Fekir S
    Neuropsychopharmacology; 2018 Jun; 43(7):1498-1509. PubMed ID: 29511334
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Brain gamma-aminobutyric acid (GABA) abnormalities in bipolar disorder.
    Brady RO; McCarthy JM; Prescot AP; Jensen JE; Cooper AJ; Cohen BM; Renshaw PF; Ongür D
    Bipolar Disord; 2013 Jun; 15(4):434-9. PubMed ID: 23634979
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mania, glutamate/glutamine and risperidone in pediatric bipolar disorder: a proton magnetic resonance spectroscopy study of the anterior cingulate cortex.
    Moore CM; Biederman J; Wozniak J; Mick E; Aleardi M; Wardrop M; Dougherty M; Harpold T; Hammerness P; Randall E; Lyoo IK; Renshaw PF
    J Affect Disord; 2007 Apr; 99(1-3):19-25. PubMed ID: 17005256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.